Clinical Trial Update: Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the completion of a study evaluating whether AZD1656 influences the pharmacokinetics of digoxin in patients with Type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656
• DIGOXIN (Digoxin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED